Lufthansa Cargo has announced a premium airfreight pharma product specifically developed for the transport of COVID-19 vaccines.

COVID-19 Temp Premium will be available to book from January 11 and will provide comprehensive and personalized customer service along the travel chain, including monitoring of vaccine shipments throughout the entire process and a 24/7 after sales support.

Additionally, COVID-19 Temp Premium includes high priority capacity access, Lufthansa Cargo’s fastest speed option in combination with temperature focus and a comprehensive security concept as well as bookability throughout the entire Lufthansa Cargo network.

Said Peter Gerber, CEO of Lufthansa Cargo: “The distribution of temperature- and time-sensitive pharmaceuticals is extremely demanding. We were one of the first airlines to specialize in the transport of medical goods and pharmaceuticals and can therefore draw on many years of experience.

“Thanks to the recent expansion of our ground infrastructure, we can also handle larger volumes and transport them worldwide while supporting our customers to maintain the cold chain.

“In 2019, we transported around 100,000 tons of pharmaceuticals. We are ready to make another important contribution to overcoming the pandemic by distributing the vaccines worldwide.”

For the transport of pharmaceuticals, three temperature ranges (based on the ambient temperature) are available in airfreight: Controlled Room Temperature for shipments with transport temperature range of +15°C to +25°C, cool storage for shipments with transport temperature range of +2°C to +8°C and deep frozen storage for shipments with transport temperature range of -10°C or below.

By using special refrigerated containers and means, such as dry ice, the most diverse requirements of pharmaceutical manufacturers can be met. Lufthansa Cargo also has experience with transports in the ultra-frozen range (-70°C).

The specific packaging, transport, handling and storage requirements of the various COVID-19 vaccines, and the quantities to be transported, by which routes and over which periods of time, are partly still open.

The actual transport routes of the vaccines depend largely on the future production sites for approved vaccines and the respective recipient markets. With its current freighter fleet of 18 aircraft, Lufthansa Cargo is able to respond flexibly to shifts in demand. If necessary, the provision of additional belly capacity can also be examined.

Lufthansa Cargo uses the global network of its own freighter aircraft as well as the flights of Lufthansa, Austrian Airlines, Brussels Airlines and Eurowings that are open for cargo. Clients consist of air freight forwarding companies.

For the handling of goods at the airports, the airfreight subsidiary organizes the necessary ground infrastructure. Even before the pandemic, Lufthansa Cargo had already invested heavily in its temperature control facilities, including the brand new Lufthansa Cargo Pharma Hub Munich as well as the recently extended and upgraded Lufthansa Cargo Pharma Center Chicago at O’Hare International Airport.

With its pharmaceutical hubs and up to 200 other stations with Active Temp Control or Passive Temp Support services worldwide, Lufthansa Cargo has one of the world’s largest airline pharmaceutical networks. 30 of these stations are already CEIV Pharma-certified.

Lufthansa Cargo was one of the first airlines worldwide by IATA to be CEIV-Pharma certified and is continuing to expand its network of certified stations worldwide.